Canada markets open in 1 hour 14 minutes

Altimmune, Inc. (3G0.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
6.82-0.06 (-0.86%)
As of 08:12AM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 489.54M
Enterprise Value 320.45M
Trailing P/E 3.57
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)1.05k
Price/Book (mrq)3.03
Enterprise Value/Revenue 838.81
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 0.10
52-Week Change 3105.65%
S&P500 52-Week Change 324.96%
52 Week High 313.70
52 Week Low 31.97
50-Day Moving Average 36.59
200-Day Moving Average 36.46

Share Statistics

Avg Vol (3 month) 3413
Avg Vol (10 day) 3718
Shares Outstanding 570.9M
Implied Shares Outstanding 671.21M
Float 870.34M
% Held by Insiders 10.78%
% Held by Institutions 163.27%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4Jan 20, 2017
Last Split Factor 21:30
Last Split Date 3Sept 14, 2018

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Mar 31, 2024

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-535,879.98%

Management Effectiveness

Return on Assets (ttm)-29.48%
Return on Equity (ttm)-54.46%

Income Statement

Revenue (ttm)410k
Revenue Per Share (ttm)0.01
Quarterly Revenue Growth (yoy)-76.20%
Gross Profit (ttm)N/A
EBITDA -88.09M
Net Income Avi to Common (ttm)-92.77M
Diluted EPS (ttm)-1.49
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)182.02M
Total Cash Per Share (mrq)2.57
Total Debt (mrq)552k
Total Debt/Equity (mrq)0.32%
Current Ratio (mrq)16.55
Book Value Per Share (mrq)2.44

Cash Flow Statement

Operating Cash Flow (ttm)-72.76M
Levered Free Cash Flow (ttm)-45.06M